FDA Approves First Generic Symbicort Inhaler
On March 15th, 2022, the FDA announced that a generic for the brand name inhaler Symbicort was approved for use in the United States. This marks a huge step forward in making inhalers for people with asthma or Chronic Obstructive Pulmonary Disease (COPD) more...
New Injectable Medication to Treat Severe Asthma
Asthma Background Asthma is a respiratory health condition that ranges from mild to serious for those who suffer from it. Those with asthma experience narrowing and swelling of their airways, which can make it difficult to breath. This may lead to symptoms of...
Expanded approval of Jardiance for Heart Failure
Heart Failure Background Heart failure is a serious type of health condition that is characterized by symptoms such as shortness of breath and/or swelling of the ankles, legs, or other extremities. People with heart failure might be short of breath with activity, or...
